TRT and HbA1c in Diabetic Men: Improving Glycemic Control

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

For hypogonadal men with type 2 diabetes, testosterone replacement therapy (TRT) has consistently demonstrated significant improvements in HbA1c levels, often leading to better long-term glycemic control. This benefit is primarily mediated through enhanced insulin sensitivity, favorable changes in body composition, and a reduction in systemic inflammation, making TRT a valuable adjunct to conventional diabetes management.

TRT and HbA1c in Diabetic Men: A Path to Better Glycemic Control

Type 2 diabetes is a chronic condition characterized by high blood glucose levels, often measured by glycated hemoglobin (HbA1c), which reflects average blood sugar over the past two to three months. For many men with type 2 diabetes, particularly those who are also hypogonadal (have low testosterone), achieving optimal glycemic control can be challenging. Fortunately, testosterone replacement therapy (TRT) has emerged as a powerful tool that can significantly improve HbA1c levels and overall metabolic health in this population.

The Link Between Low Testosterone and Poor Glycemic Control

It's well-established that low testosterone is highly prevalent in men with type 2 diabetes, affecting up to 50% of them. This isn't merely a coincidence; low testosterone contributes to a vicious cycle of metabolic dysfunction. You'll often see increased insulin resistance, where the body's cells become less responsive to insulin, leading to higher blood glucose. This, in turn, can further suppress testosterone production, creating a self-perpetuating problem. The result is often higher HbA1c levels, increased abdominal fat, and a greater risk of cardiovascular complications.

How TRT Improves HbA1c in Diabetic Men

Restoring testosterone to physiological levels through TRT can break this cycle and lead to clinically meaningful improvements in glycemic control:

• Enhanced Insulin Sensitivity: The primary mechanism by which TRT lowers HbA1c is by improving insulin sensitivity. Studies have consistently shown that TRT can make muscle and fat cells more responsive to insulin, allowing glucose to be taken up and utilized more efficiently. For example, a meta-analysis by Saad et al. (2017) demonstrated that TRT significantly reduced HbA1c by an average of 0.67% in hypogonadal men with type 2 diabetes.
• Favorable Body Composition Changes: Testosterone is a potent anabolic hormone. TRT typically leads to an increase in lean muscle mass and a reduction in fat mass, especially visceral fat (the fat surrounding abdominal organs). Increased muscle mass improves glucose disposal, as muscle is a major site of glucose uptake. Reduced visceral fat decreases the release of inflammatory mediators that contribute to insulin resistance.
• Reduced Systemic Inflammation: Low testosterone is associated with chronic low-grade inflammation, which plays a role in insulin resistance and diabetes progression. TRT has been shown to reduce markers of inflammation, such as C-reactive protein (CRP), further contributing to improved metabolic health.

These combined effects lead to a more efficient glucose metabolism, resulting in lower fasting glucose levels and, consequently, a reduction in HbA1c.

Clinical Evidence and Outcomes

Numerous studies have supported the benefits of TRT on HbA1c in diabetic men:

• A real-world audit revealed that men with type 2 diabetes using testosterone therapy lowered HbA1c by 0.5 percentage points at 6 months (Healio, 2025).
• Long-term studies have shown that TRT can not only improve HbA1c but also prevent the progression of prediabetes to type 2 diabetes in hypogonadal men (Haider et al., 2019).
• A systematic review and meta-analysis of randomized controlled trials by Xu et al. (2020) concluded that TRT significantly reduced HbA1c in hypogonadal men with type 2 diabetes or metabolic syndrome.

Unlike some diabetes medications that primarily focus on glucose lowering, TRT addresses underlying metabolic dysfunction, offering a more holistic approach to improving glycemic control.

Practical Takeaway

If you're a diabetic man with low testosterone, TRT can be a game-changer for your glycemic control. You'll likely see a significant drop in your HbA1c levels, often within 6-12 months, making it easier to manage your diabetes. This isn't just about numbers; it's about improving your body's ability to handle sugar, reducing your risk of long-term diabetes complications. Your doctor will monitor your HbA1c and other metabolic markers closely. Remember, TRT works best when combined with a healthy diet and regular exercise, so don't neglect those foundational lifestyle changes.